Vaxcyte
PCVX · NASDAQ
Bulios Fair Price
$34.37
42.0% downside
Trenutna cena
$59.21
Po podatkih Bulios Fair Price je delnica PCVX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Vaxcyte is an American biotechnology company focused on developing vaccines for the prevention of serious infectious diseases. The company specializes in advanced vaccine technologies, including cellular therapies and protein-based vaccines, with the aim of providing effective protection against pathogens that currently lack sufficient vaccines. Vaxcyte is developing vaccines for infections such as pneumococcal disease and is working to improve immunization and the prevention of infectious diseases globally.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Grant E. Pickering
Employees
507
Headquarters
San Carlos
Prihajajoči dogodki
Earnings
Upcoming earnings report